Three out of 30 patients of leprosy getting clofazimine therapy developed severe gastrointestinal side effects following the therapy in the dose of 100 mg after one month, eight months and five weeks respectively. One of the patients died due to the side effects. Indian patients appear to be more prone to severe gastrointestinal side effects of clofazimine and may develop the same after shorter duration of therapy with smaller doses of the drug.
BT - Leprosy in India C1 - http://www.ncbi.nlm.nih.gov/pubmed/7253579?dopt=Abstract CN - Infolep Library - available DA - 1981 Apr IS - 2 J2 - Lepr India LA - eng N2 -Three out of 30 patients of leprosy getting clofazimine therapy developed severe gastrointestinal side effects following the therapy in the dose of 100 mg after one month, eight months and five weeks respectively. One of the patients died due to the side effects. Indian patients appear to be more prone to severe gastrointestinal side effects of clofazimine and may develop the same after shorter duration of therapy with smaller doses of the drug.
PY - 1981 SP - 285 EP - 8 T2 - Leprosy in India TI - Gastro-intestinal side effects of clofazimine. VL - 53 SN - 0024-1024 ER -